2023 annual financial data
Verrica Pharmaceuticals 2023 Operating margin
Verrica Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was -1,283.35%.
Operating income was -65,759,000 USD and net income was -66,995,000 USD.
Operating cash flow was -38,577,000 USD.
Get free Verrica Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,124,000 USD
- Operating income
- -65,759,000 USD
- Net income
- -66,995,000 USD
- Operating cash flow
- -38,577,000 USD